← board
ELAN
distress 2/10 · well-funded / low risk$25.16-1%today-6% from 52w high
Lead: canine dermatitis
Revenue
$1371M
Liquidity
$428M
Runway
—
Shares 1y
+1%
Price & events
+1.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.7%
1D
-3.0%
1W
+8.5%
1M
+12.4%
3M
+3.1%
6M
+67.5%
1Y
+89.7%
2Y
-31.1%
5Y
-17.5%
All
Overview
- Market Cap
- $12.57B
- Enterprise Value
- $15.87B
- Volume
- 302.32K
- 52 Week Range
- $13.68 – $26.84
- Total Shares
- 499.45M
- Float Shares
- 494.82M
- Short %
- 11.21%
- % Held by Insiders
- 1.22%
- % Held by Institutions
- 111.51%
- RVOL
- 0.07x
- Beta
- 1.69
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 4
- 2026-08-05Estimated 45%earningsEarningsEarnings releaseyahoo
- Q4 2025readoutBefrena (tirnovetmab) · Administrative review and approval expected in Q4 2025.SEC 8-K
- 2025-03-16partnershipgene therapy (life extension) · Partnership to explore emerging spaces for increasing healthy lifespan in petsSEC 8-K
- 2025-03-16partnershipgene therapy (targeting CKD) · Research agreement with WEDterinary to explore gene therapy for chronic kidney disease in cats and life extensionSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $30 (+19% upside) · 14 analysts
- 2026-06-18TD CowenBuy
- 2026-05-07CitigroupBuy
- 2026-05-07JP MorganOverweight
- 2026-04-15CitigroupBuy
- 2026-02-25KeybancOverweight
- 2026-02-25Morgan StanleyEqual-Weight
Competitors — canine dermatitis
- none identified
Recent news
- 2026-07-22Morgan Stanley Issues Positive Forecast for Elanco Animal Health (NYSE:ELAN) Stock Price - MarketBeat
- 2026-07-21Dimensional Fund Advisors LP Has $586.92 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
- 2026-07-20Jennison Associates LLC Purchases 494,216 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
- 2026-07-20Principal Financial Group Inc. Grows Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
- 2026-07-18472,814 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Dorsey Wright & Associates - MarketBeat
- 2026-07-18Allspring Global Investments Holdings LLC Acquires New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
- 2026-07-17Geneos Wealth Management Inc. Purchases 196,884 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
- 2026-07-16Fifth Third Bancorp Grows Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.